Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Carboplatin in Metastatic Breast Cancer
NCT00005963Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Nov 2000
- Primary completion
- Oct 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, carboplatin in breast cancer, sponsored by Cancer and Leukemia Group B. Started Nov 2000; status: completed.
02
Drugs
docetaxelcarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00005963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005963.